Rare Disease Report
Physicians
Physicians
Patients & Caregivers

Is Maintenance Therapy with Rituximab for Follicular Lymphoma a Good Idea?

DECEMBER 12, 2016
Paul Barr, MD
Paul Barr, MD of the University of Rochester discusses data presented at the 58th Annual ASH Meeting & Exposition showing the long term efficacy and safety (and discontinuation rate) using sequential RCHOP, radioimmunotherapy and rituximab maintenance therapy in advanced follicular lymphoma. 
 

Reference

Barr PM, Li H, Burack R, et al.  Sequential RCHOP, Radioimmunotherapy and Rituximab Maintenance Improves Early Outcomes in Advanced Stage Follicular Lymphoma: 5 Year Outcomes from SWOG 0801. Presented at the 58th ASH Annual Meeting & Exposition; San Diego, CA: December 3-6, 2016. Abstract 614.


Copyright © RareDR 2013-2017 Rare Disease Communications. All Rights Reserved.